{"slug":"kolon-tissuegene","name":"코오롱티슈진","name_en":"Kolon TissueGene","ticker":"950160.KQ","updated_at":"2026-07-11T10:22:09.616+00:00","canonical":"https://valuechain.wiki/kolon-tissuegene","kicker":"코스닥 대형주","kicker_en":"KOSDAQ large cap","lead":"골관절염 유전자 치료제 인보사를 개발하는 코오롱 계열 바이오 기업이다. 코스닥 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A Kolon-affiliated biotech developing the osteoarthritis gene therapy Invossa. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"유전자 치료제 개발(인보사·TG-C)"}]},"segments_en":{"parts":[{"name":"Gene therapy development (Invossa/TG-C)"}]},"returns_yearly":{"2021":0,"2022":22.2,"2023":19.4,"2024":145.5,"2025":265.9,"2026":-14.3},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}